Abstract
An exogenous redox-free, membrane-less enzyme biofuel cell-based ultrasensitive self-powered cytosensing platform was fabricated. With the ultrahigh sensitivity and the merits of not requiring external power sources or exogenous reagents, the device has great potential as a point-of-care tool for early diagnosis of cancer in vivo.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Bioelectric Energy Sources*
-
Biosensing Techniques*
-
Diagnostic Techniques and Procedures / instrumentation*
-
Diagnostic Techniques and Procedures / standards
-
Electrochemical Techniques / instrumentation
-
Humans
-
Limit of Detection
-
Neoplasms / diagnosis*
-
Oxidation-Reduction
-
Oxidoreductases Acting on CH-CH Group Donors / metabolism
-
Point-of-Care Systems*
Substances
-
Oxidoreductases Acting on CH-CH Group Donors
-
bilirubin oxidase